Guru Ownership Trend
Guru Analysis for Arcutis Biotherapeutics, Inc. (ARQT)
Arcutis Biotherapeutics, Inc. (ARQT), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $26.7 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $3 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who increased their stake by 715.3%. Conversely, Paul Tudor Jones reduced exposure by 88.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Arcutis Biotherapeutics, Inc. (ARQT)
Major holders include Cliff Asness ($13.28 M), Renaissance Technologies (RenTech) ($12.58 M), Joel Greenblatt ($498,496). According to the latest reported data, 4 tracked investment managers collectively hold approximately 1.01 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $3 M, with 2 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 1 fully exited ARQT. The total reported sell value was $12.59 M.
Yes, 0 managers opened new positions in ARQT, and 2 increased their existing holdings. The total reported buy value was $15.59 M.